You just read:

The Zacks Analyst Blog Highlights: Enzon Pharmaceuticals, Merck, Pfizer, UCB Pharma and Eastman Chemical Company

News provided by

Zacks Investment Research, Inc.

Sep 13, 2011, 09:30 ET